- Home
- ATKR vs CLDX Comparison
ATKR vs CLDX Comparison
Compare ATKR & CLDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ATKR | CLDX |
|---|---|---|
| Founded | 1959 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Biotechnology: In Vitro & In Vivo Diagnostic Substances |
| Sector | Miscellaneous | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.5B | 2.6B |
| IPO Year | 2016 | 1995 |
Fundamental Metrics
Financial Performance| Metric | ATKR | CLDX |
|---|---|---|
| Price | $75.37 | $35.59 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 4 | 10 |
| Target Price | ★ $75.67 | $46.60 |
| AVG Volume (30 Days) | 268.9K | ★ 1.0M |
| Earning Date | 05-05-2026 | 05-04-2026 |
| Dividend Yield | ★ 1.75% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $2,850,378,000.00 | $12,743,000.00 |
| Revenue This Year | $6.55 | $111.39 |
| Revenue Next Year | $3.89 | $235.85 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 87.78 |
| 52 Week Low | $53.49 | $19.72 |
| 52 Week High | $90.16 | $40.30 |
Technical Indicators
Market Signals| Indicator | ATKR | CLDX |
|---|---|---|
| Relative Strength Index (RSI) | 51.22 | 52.21 |
| Support Level | $68.88 | $28.51 |
| Resistance Level | $79.03 | $40.30 |
| Average True Range (ATR) | 2.45 | 1.45 |
| MACD | 0.52 | -0.42 |
| Stochastic Oscillator | 75.31 | 41.32 |
Price Performance
Historical ComparisonAbout ATKR Atkore Inc.
Atkore Inc is a manufacturer of Electrical products for the non-residential construction and renovation markets, as well as residential markets, and Safety & Infrastructure products for the construction and industrial markets. The Electrical segment manufactures products used in the construction of electrical power systems including conduit, cable, and installation accessories. This segment serves contractors in partnership with the electrical wholesale channel. The Safety & Infrastructure segment designs and manufactures solutions including metal framing, mechanical pipe, perimeter security, and cable management. These solutions are marketed to contractors, original equipment manufacturers (OEMs), and end-users. The majority of revenue is generated from the Electrical segment.
About CLDX Celldex Therapeutics Inc.
Celldex Therapeutics Inc is a biopharmaceutical firm focused on mast cell biology and the development of therapeutic antibodies. Its pipeline includes monoclonal and bispecific antibodies aimed at treating severe inflammatory, allergic, autoimmune, and other mast cell-mediated diseases. The company operates in a single operating and reportable segment in the business of development, manufacturing and commercialization of novel therapeutics for human health care.